News

EUnetHTA 21 announces that the public consultation for four deliverables D4.3.1 Practical guideline on comparators and comparisons, D5.2 Guidance on JCA Assessment Report Template, D7.2

EUnetHTA 21 is pleased to announce the publication of three deliverables: D4.3.2 Methodological Guideline on direct and indirect comparisons; D4.7.1/2 Synthesis of national requirements /

EUnetHTA 21 announces that the public consultation for the deliverable D7.1 – Guidance on interaction between Health Technology Developer and HTA  is open until 19.08.2022,

EUnetHTA 21 announces that the public consultation for three deliverables D4.5 Applicability of Evidence; D4.6 Validity of clinical studies and D5.1 Guidance for JCA Submission

EUnetHTA 21 is pleased to announce the publication of the deliverable D5.3.1 on selection criteria for JCA assessor and co-assessor. More information can be found

EUnetHTA 21 announces that the public consultation for D4.7.3/D4.7.4 (EUDAMED data reporting template / Guidance for EUDAMED-based TISP process) is open until 05.07.2022, 23:59 CET.

EUnetHTA 21 launches the second Open Call for applications from the pharmaceutical industry for five Joint Scientific Consultations (JSCs). The Open Call will remain open

EUnetHTA 21 announces that the public consultation for D4.2 (scoping process), D4.3.2 (guideline for comparators and comparisons) and D4.7.1/4.7.2 (framework for assessment of high-risk MD) is

EUnetHTA 21 announces that the public consultation for D5.3.2 – HTAb technical expert working groups is open until 20-05-2022, 23:59 CET. The draft deliverable as well as the

The EUnetHTA 21 Consortium is pleased to announce that the EUnetHTA 21-EMA Work Plan is now publicly available. We would like to thank everyone who